Work

A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines

Year: 2018

Type: article

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2018.06.004

Authors: Shengxiang Ren, Christopher J. Rivard, Hui Yu, Carlo Genova, Leslie Rozenboom, Dexiang Gao, Trista K. Hinz, Brad A. Rikke, Murry W. Wynes, Charles Caldwell, Francesco Agustoni, Kenichi suda, Tao Jiang, Caicun Zhou, Lynn E. Heasley, Fred R. Hirsch

Institutions: Tongji University, Shanghai Pulmonary Hospital, University of Colorado Cancer Center, University of Colorado Anschutz, University of Genoa, University of Colorado Denver

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G3413569888, SPORE in Lung Cancer, University of Colorado Cancer Center Support Grant

OpenAlex ID: W2810416587

FWCI: 0.507

Cites: 29

Cited by: 6

Related to: 10